文献速递术前评估与围术期医学小儿麻醉

南非儿童外科结局研究-2:口服铁剂治疗择期非心脏手术患儿缺铁性贫血的前瞻性多中心前后对照研究

South African Paediatric Surgical Outcomes Study-2 (SAPSOS-2): a prospective multi-centre pre-post study evaluating haemoglobin response to oral iron for iron-deficiency anaemia in children undergoing elective noncardiac surgery.
PubMed 文献 · Br J Anaesth · 2026-07-01

该研究在南非两家学术医院前瞻性纳入755例择期非心脏手术患儿,采用床旁HemoCue®筛查贫血,确诊缺铁性贫血者接受口服铁剂和选择性驱虫治疗。结果显示筛查贫血患病率23.4%,确诊贫血者中缺铁性贫血占54.9%,口服铁剂后血红蛋白中位升高1.0 g dl-1(P=0.001),65.7%贫血严重程度改善,48.6%贫血消退,该路径可行。

要点

  • 床旁HemoCue®筛查可发现约23.4%患儿贫血,确诊贫血者中54.9%为缺铁性贫血。
  • 口服铁剂后血红蛋白中位升高1.0 g dl-1,48.6%患儿贫血消退。
  • 该术前贫血管理路径在南非资源有限环境中可行,依从性高且副作用少。

核心结论

  • 该务实的术前贫血管理路径可行,并使缺铁性贫血患儿血红蛋白适度升高。
  • 研究结果支持在资源有限环境中进一步评估结构化优化路径。

研究设计与样本

  • 前瞻性务实性前后对照研究,在南非两家学术医院开展,时间为2023年2月至2025年3月。
  • 纳入年龄>6个月至<16岁、接受择期非心脏手术的儿童,先用床旁毛细血管HemoCue®筛查,实验室确诊缺铁性贫血者接受口服铁剂和选择性驱虫。
  • 主要结局为血红蛋白变化(ΔHb),次要结局包括床旁筛查贫血患病率、确诊贫血者中缺铁性贫血比例、贫血改善或消退及可行性指标。

主要发现

  • 术前HemoCue®筛查显示177/755(23.4%;95%CI 20.4-26.6%)患儿血红蛋白低于WHO年龄别阈值。
  • 175例接受实验室确诊检查的患儿中,71/175(40.6%)存在贫血;其中39/71(54.9%)为缺铁性贫血,35/39(89.7%)完成随访。
  • 缺铁性贫血患儿口服铁剂后血红蛋白中位变化为1.0 g dl-1(四分位距0.5-1.8;P=0.001)。
  • WHO贫血严重程度分类改善者23/35(65.7%),贫血消退者17/35(48.6%)。
  • 依从性高,副作用不常见。

临床怎么用

  • 对择期非心脏手术患儿可采用床旁HemoCue®进行术前贫血筛查。
  • 对实验室确诊的缺铁性贫血患儿可给予口服铁剂和选择性驱虫治疗,并随访血红蛋白反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preoperative anaemia in children is associated with increased morbidity, mortality, and blood transfusion exposure. This study aimed to evaluate a pragmatic preoperative anaemia pathway and the haemoglobin (Hb) response (ΔHb) to oral iron in children with iron-deficiency anaemia (IDA) undergoing elective noncardiac surgery in South Africa. METHODS: This prospective pragmatic study with a pre-post design was conducted at two academic hospitals in South Africa from February 2023 to March 2025. Children aged >6 months to <16 yr were first screened using point-of-care capillary HemoCue®. Children with laboratory-confirmed IDA received oral iron and selective deworming. The primary outcome was ΔHb. Secondary outcomes included anaemia prevalence detected by point-of-care screening with HemoCue®, proportion of IDA among children with laboratory-confirmed anaemia, improvement or resolution of anaemia, and feasibility measures. RESULTS: On preoperative HemoCue® screening, 177/755 (23.4%; 95% confidence interval 20.4-26.6%) children had Hb concentrations below WHO age-specific thresholds. Among the 175 children who underwent confirmatory laboratory testing, 71/175 (40.6%) had anaemia. Of these, 39/71 (54.9%) had IDA, with 35/39 (89.7%) completing follow-up. Median ΔHb was 1.0 g dl-1 (interquartile range 0.5-1.8; P=0.001). The WHO anaemia severity category (defined as mild, moderate or severe) improved in 23/35 (65.7%) children, and 17/35 (48.6%) were no longer anaemic. Adherence was high and side effects infrequent. CONCLUSIONS: This pragmatic preoperative anaemia-management pathway was feasible and produced a modest increase in Hb in children with IDA. These findings highlight the potential role of structured optimisation pathways and support further evaluation in resource-limited settings. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT05681871).

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Meyer HM, Torborg A, Biccard B, et al. South African Paediatric Surgical Outcomes Study-2 (SAPSOS-2): a prospective multi-centre pre-post study evaluating haemoglobin response to oral iron for iron-deficiency anaemia in children undergoing elective noncardiac surgery. Br J Anaesth. 2026. PMID: 42386436. doi:10.1016/j.bja.2026.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。